data13F

AXSM – Axsome Therapeutics Inc

Held by 1 of 30 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares125,808
Combined reported value$23.2M

AXSM chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Ray Dalio narrow view 0.10 Added 116.1%125,808$23.2MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Ray Dalio narrow view Added 116.1%125,8080.05
Q2 2026Ray Dalio narrow view Added 2.2%58,2170.00
Q1 2026Ray Dalio narrow view Added 20.0%56,9510.01
Q4 2025Ray Dalio narrow view New47,4440.03

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Ray Dalio narrow view Added 116.1%125,8080.05
Q2 2026Ray Dalio narrow view Added 2.2%58,2170.00
Q1 2026Ray Dalio narrow view Added 20.0%56,9510.01
Q4 2025Ray Dalio narrow view New47,4440.03

Reduced: reduced or closed

No tracked investor reduced or closed this position in the last 4 quarters.

History

1 peakQ3 2026: 1 tracked investors
Q1 2025: 1 tracked investorsQ2 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20252026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Ray Dalio125.8K58.2K57.0K47.4K–107.3K42.8K–

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).